The Journal of Thoracic and Cardiovascular Surgery
Volume 138, Issue 4 , Pages 994-1001 , October 2009

Association of electrostimulation with cell transplantation in ischemic heart disease

  • Abdel Shafy, MD

      Affiliations

    • Laboratory of Biosurgical Research, Pompidou Hospital, University of Paris, Paris, France
    • ,
  • Thomas Lavergne, MD

      Affiliations

    • Department of Cardiology, Pompidou Hospital, University of Paris, Paris, France
    • ,
  • Christian Latremouille, MD, PhD

      Affiliations

    • Laboratory of Biosurgical Research, Pompidou Hospital, University of Paris, Paris, France
    • ,
  • Miguel Cortes-Morichetti, MD

      Affiliations

    • Department of Cardiology, Pompidou Hospital, University of Paris, Paris, France
    • ,
  • Alain Carpentier, MD, PhD

      Affiliations

    • Laboratory of Biosurgical Research, Pompidou Hospital, University of Paris, Paris, France
    • ,
  • Juan C. Chachques, MD, PhD

      Affiliations

    • Laboratory of Biosurgical Research, Pompidou Hospital, University of Paris, Paris, France
    • Corresponding Author InformationAddress for reprints: Juan C. Chachques, MD, PhD, Department of Cardiovascular Surgery, Pompidou Hospital, 20 rue Leblanc, 75015 Paris, France.

Received 30 July 2008 ,Revised 2 January 2009 ,Accepted 3 February 2009.

References 

  1. McCue JD, Swingen C, Feldberg T, Caron G, Kolb A, Denucci C, et al. The real estate of myoblast cardiac transplantation: negative remodeling is associated with location. J Heart Lung Transplant. 2008;27:116–123
  2. Suuronen EJ, Price J, Veinot JP, Ascah K, Kapila V, Guo XW, et al. Comparative effects of mesenchymal progenitor cells, endothelial progenitor cells, or their combination on myocardial infarct regeneration and cardiac function. J Thorac Cardiovasc Surg. 2007;134:1249–1258
  3. Chachques JC, Salanson-Lajos C, Lajos P, Shafy A, Alshamry A, Carpentier A. Cellular cardiomyoplasty for myocardial regeneration. Asian Cardiovasc Thorac Ann. 2005;13:287–296
  4. Kan CD, Li SH, Weisel RD, Zhang S, Li RK. Recipient age determines the cardiac functional improvement achieved by skeletal myoblast transplantation. J Am Coll Cardiol. 2007;50:1086–1092
  5. Robey TE, Saiget MK, Reinecke H, Murry CE. Systems approaches to preventing transplanted cell death in cardiac repair. J Mol Cell Cardiol. 2008;45:567–581
  6. Jolicoeur EM, Granger CB, Fakunding JL, Mockrin SC, Grant SM, Ellis SG, et al. Bringing cardiovascular cell-based therapy to clinical application: perspectives based on a National Heart, Lung, and Blood Institute Cell Therapy Working Group meeting. Am Heart J. 2007;153:732–742
  7. Chachques JC, Acar C, Herreros J, Trainini JC, Prosper F, D'Attellis N, et al. Cellular cardiomyoplasty: clinical application. Ann Thorac Surg. 2004;77:1121–1130
  8. Auricchio A, Prinzen FW. Update on the pathophysiological basics of cardiac resynchronization therapy. Europace. 2008;10:797–800
  9. Cazeau S, Alonso C, Jauvert G, Lazarus A, Ritter P. Cardiac resynchronization therapy. Europace. 2004;5(Suppl 1):S42–S48
  10. Nagueh SF. Mechanical dyssynchrony in congestive heart failure: diagnostic and therapeutic implications. J Am Coll Cardiol. 2008;51:18–22
  11. Chachques JC, Abdel Shafy AB, Duarte F, Cattadori B, Goussef N, Shen L, et al. From dynamic to cellular cardiomyoplasty. J Card Surg. 2002;17:194–200
  12. Monnet E, Chachques JC. Animal models of heart failure: what is new?. Ann Thorac Surg. 2005;79:1445–1453
  13. Yankey GK, Li T, Kilic A, Cheng G, Satpute A, Savai K, et al. Regional remodeling strain and its association with myocardial apoptosis after myocardial infarction in an ovine model. J Thorac Cardiovasc Surg. 2008;135:991–998998.e1-2
  14. Jessup M, Brozena SC. Guidelines for the management of heart failure: differences in guideline perspectives. Cardiol Clin. 2007;25:497–506
  15. Cleland JG, Coletta AP, Abdellah AT, Cullington D, Clark AL, Rigby AS. Clinical trials update from the American Heart Association 2007: CORONA, RethinQ, MASCOT, AF-CHF, HART, MASTER, POISE and stem cell therapy. Eur J Heart Fail. 2008;10:102–108
  16. Rajnoch C, Chachques JC, Berrebi A, Bruneval P, Benoit MO, Carpentier A. Cellular therapy reverses myocardial dysfunction. J Thorac Cardiovasc Surg. 2001;121:871–878
  17. Chachques JC, Duarte F, Cattadori B, Shafy A, Lila N, Chatellier G, et al. Angiogenic growth factors and/or cellular therapy for myocardial regeneration: a comparative study. J. Thorac Cardiovasc Surg. 2004;128:245–253
  18. Carvalho KA, Simeoni RB, Guarita-Souza LC, Francisco JC, Abdelwahid E, Myiague NI, et al. Angiogenesis without functional outcome after mononuclear stem cell transplant in a doxorubicin-induced dilated myocardiopathy murine model. Int J Artif Organs. 2008;31:431–438
  19. Chachques JC. Cardiomyoplasty: is it still a viable option in patients with end-stage heart failure?. Eur J Cardiothorac Surg. 2009;35:201–203
  20. Iijima Y, Nagai T, Mizukami M, Matsuura K, Ogura T, Wada H, et al. Beating is necessary for transdifferentiation of skeletal muscle-derived cells into cardiomyocytes. FASEB J. 2003;17:1361–1363
  21. Mills WR, Mal N, Kiedrowski MJ, Unger R, Forudi F, Popovic ZB, et al. Stem cell therapy enhances electrical viability in myocardial infarction. J Mol Cell Cardiol. 2007;42:304–314
  22. Carraro U. Long-term aneurally regenerated skeletal myofibers into heart: how long they could survive and grow by phasic daily FES?. Basic Appl Myol. 2003;13:53–63
  23. Genovese JA, Spadaccio C, Chachques E, Schussler O, Carpentier A, Chachques JC, et al. Cardiac pre-differentiation of human mesenchymal stem cells by electrostimulation. Fron Biosci. 2009;14:2996–3002
  24. Hu X, Yu SP, Fraser JL, Lu Z, Ogle ME, Wang JA, et al. Transplantation of hypoxia-preconditioned mesenchymal stem cells improves infarcted heart function via enhanced survival of implanted cells and angiogenesis. J Thorac Cardiovasc Surg. 2008;135:799–808
  25. Memon IA, Sawa Y, Miyagawa S, Taketani S, Matsuda H. Combined autologous cellular cardiomyoplasty with skeletal myoblasts and bone marrow cells in canine hearts for ischemic cardiomyopathy. J Thorac Cardiovasc Surg. 2005;130:646–653
  26. Cortes-Morichetti M, Frati G, Schussler O, Van Huyen JP, Lauret E, et al. Association between a cell-seeded collagen matrix and cellular cardiomyoplasty for myocardial support and regeneration. Tissue Eng. 2007;13:2681–2687
  27. Chachques JC, Trainini JC, Lago N, Cortes-Morichetti M, Schussler O, Carpentier A. Myocardial Assistance by Grafting a New Bioartificial Upgraded Myocardium (MAGNUM trial): clinical feasibility study. Ann Thorac Surg. 2008;85:901–908
  28. Schussler O, Coirault C, Louis-Tisserand M, Al Chare W, Oliviero P, Menard C, et al. Use of arginine-glycine-aspartic acid adhesion peptides coupled with a new collagen scaffold to engineer a myocardium-like tissue graft. Nat Clin Pract Cardiovasc Med. 2009;6:240–249
  29. Conti JB, Sears SF. Cardiac resynchronization therapy: can we make our heart failure patients smarter?. Trans Am Clin Climatol Assoc. 2007;118:153–164
  30. Young JB, Abraham WT, Smith AL, Leon AR, Lieberman R, Wilkoff B, et al. Combined cardiac resynchronization and implantable cardioversion defibrillation in advanced chronic heart failure: the MIRACLE ICD Trial. JAMA. 2003;289:2685–2694
  31. Doll N, Piorkowski C, Czesla M, Kallenbach M, Rastan AJ, Arya A, et al. Epicardial versus transvenous left ventricular lead placement in patients receiving cardiac resynchronization therapy: results from a randomized prospective study. Thorac Cardiovasc Surg. 2008;56:256–261
  32. Rademakers LM, de Boeck BW, Maessen JG, Prinzen FW. Development of strategies for guiding cardiac resynchronization therapy. Heart Fail Clin. 2008;4:333–345
  33. Fauchier L, Poret P, Robin I, de Labriolle A, Giraudeau C, Cosnay P, et al. Different criteria of cardiac resynchronization therapy and their prognostic value for worsening heart failure or major arrhythmic events in patients with idiopathic dilated cardiomyopathy. Am J Cardiol. 2006;97:393–399
  34. de Sisti A, Toussaint JF, Lavergne T, Ollitrault J, Abergel E, Paziaud O, et al. Determinants of mortality in patients undergoing cardiac resynchronization therapy: baseline clinical, echocardiographic, and angioscintigraphic evaluation prior to resynchronization. Pacing Clin Electrophysiol. 2005;28:1260–1270
  35. Atoui R, Shum-Tim D, Chiu RC. Myocardial regenerative therapy: immunologic basis for the potential “universal donor cells.”. Ann Thorac Surg. 2008;86:327–334

PII: S0022-5223(09)00329-8

doi: 10.1016/j.jtcvs.2009.02.025

The Journal of Thoracic and Cardiovascular Surgery
Volume 138, Issue 4 , Pages 994-1001 , October 2009

Article Tools

* Image Usage & Resolution